EcoDrugPlus

Epoxide Hydrolase 2

Ensembl ID : ENSONIG00000003637
Gene Symbol: EPHX2
3 Cross references
203 Possible Orthologues:

Equilibrative Nucleoside Transporter 1

Ensembl ID : ENSONIG00000000841
Gene Symbol: LOC100691053
4 Cross references
209 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSONIG00000019052
Gene Symbol: ERBB3
1 Cross references
208 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3b

Ensembl ID : ENSONIG00000012148
Gene Symbol: ERBB3B
1 Cross references
206 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSONIG00000004212
Gene Symbol: ERBB4
3 Cross references
47 Possible Orthologues:

Estrogen Receptor 1

Ensembl ID : ENSONIG00000013354
Gene Symbol: ESR1
1 Cross references
215 Possible Orthologues:

Estrogen Receptor 2

Ensembl ID : ENSONIG00000001710
Gene Symbol: ESR2
3 Cross references
208 Possible Orthologues:

Estrogen Related Receptor Gamma

Ensembl ID : ENSONIG00000017162
Gene Symbol: ESRRG
4 Cross references
198 Possible Orthologues:

Exportin 1

Ensembl ID : ENSONIG00000000019
Gene Symbol: XPO1
1 Cross references
224 Possible Orthologues:

Exportin 1

Ensembl ID : ENSONIG00000002969
Gene Symbol: XPO1
3 Cross references
211 Possible Orthologues:

Farnesyl Diphosphate Synthase

Ensembl ID : ENSONIG00000006344
Gene Symbol: FDPS
4 Cross references
267 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSONIG00000013551
Gene Symbol: FDFT1
4 Cross references
220 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).